Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery And Postoperative Complications In Patients With Obstructive Sleep Apnea Undergoing Bariatric Surgery: A Double-Blind, Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2019
Price : $35 *
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 24 Jan 2019 Status changed from not yet recruiting to recruiting.
- 13 Nov 2018 Planned initiation date changed from 17 Sep 2018 to 1 Dec 2018.
- 27 Sep 2018 New trial record